By proceeding, you agree to our Terms of Use and Privacy Policy.
The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.
Reflect on the dynamic research environment of the cell therapy field.
Dive into Breakthroughs and Pipeline Advancements, New Cell Therapy Platforms and Enabling Technologies Manufacturing at Scale and Commercialization.
Discuss how to overcome barriers to patient access and facilitate the clinical distribution of transformative cell therapy products.
Join Agi Hamburger, A2 Biotherapeutics; Eytan Breman, Celyad Oncology & others at the pre-event networking session expanding into cell therapy access.
Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics.
The global Life Sciences industry is dominant in today’s world. Drug development processes are progressing faster than ever before.
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.
BioViros is a biotech company providing resources for regenerative medicine.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.